Legal
FDA Balancing Act
The Food and Drug Administration (FDA) has come under a lot of scrutiny lately over safety concerns of approved drugs that were on the market but had to be recalled because of some serious adverse events reported by their customers. We can view mainly Merk’s Vioxx as the catalyst for this interest and examination [...]
Massachusetts could be Top on Biofuel Push
Not that I’m an advocate of getting all my news from one source, but one of the news sites that I make regular visits to is the Boston.com web site. Originally from a suburb of Boston, I try to keep up with what’s going on in Beantown, I follow local sports teams, and find [...]
Strengthening the FDA
Two weeks ago, I wrote a post about a couple of major points in the history of the Food and Drug Administration (FDA) and how they redefined the responsibilities of the agency. These events set up the clinical trial process, and gave the FDA the authority to insist that consumable items be both safe and [...]
A Brief FDA History Lesson
Just before a presentation I gave on Monday concerning Virtual Reality and its use in medicine, the group that had assembled was discussing a variety of current topics in the pharmaceutical and biotechnology industries. One of the attendees, Peter Castellano, caught my interest when he described an article he found in the October 2007 [...]
Ethical Dilemma
In my second post ever on this site, I wrote about the FDA Fast Track program called Pay-For-Review, and I questioned whether drug companies who took advantage of this program were being given enough scrutiny for the products they were putting to market. Interestingly, in a Boston Globe article yesterday called “Burden of Proof,” [...]
Loading ...